- Title
- Effect of Ranolazine Monotherapy on Glycemic Control in Subjects With Type 2 Diabetes
- Creators
- Robert H Eckel - Divisions of Endocrinology, Metabolism and Diabetes and Cardiology, Department of Medicine, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CORobert R Henry - Center for Metabolic Research, VA San Diego Healthcare System, San Diego, CAPatrick Yue - Cardiovascular Clinical Research, Gilead Sciences, Foster City, CAArvinder Dhalla - Department of Biology, Cardiovascular Therapeutic Area, Gilead Sciences, Fremont, CAPamela Wong - Cardiovascular Therapeutic Area, Biostatistics, Gilead Sciences, Foster City, CAPhilip Jochelson - Cardiovascular Clinical Research, Gilead Sciences, Foster City, CALuiz Belardinelli - Cardiovascular Clinical Research, Gilead Sciences, Foster City, CAJay S Skyler - Divisions of Endocrinology, Diabetes, and Metabolism, Pediatrics, and Psychology, University of Miami Miller School of Medicine, Miami, FL
- Publication Details
- Diabetes care, Vol.38(7), pp.1189-1196
- Publisher
- American Diabetes Association
- Academic Unit
- Miller School of Medicine; Diabetes Research Institute (DRI)
- Language
- English
- Resource Type
- Journal article
- PMID
- 26049552
- PMCID
- PMC4477340
- Record Identifier
- 991031576940702976
Journal article
Effect of Ranolazine Monotherapy on Glycemic Control in Subjects With Type 2 Diabetes
Diabetes care, Vol.38(7), pp.1189-1196
2015-07
PMCID: PMC4477340
PMID: 26049552
Metrics
9 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Industry collaboration
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.94 Cardiac Arrhythmia
- 1.94.470 Brugada Syndrome
- Web Of Science research areas
- Endocrinology & Metabolism
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites